The  Ninth Meeting of the Parties  decided in  Dec. IX/18:      To note with appreciation the excellent work done by the Technology and Economic Assessment Panel and its Technical Options Committees;   That the levels of production and consumption necessary to satisfy essential uses of CFC-11, CFC-12, CFC-113 and CFC-114, for metered-dose inhalers (MDIs) for asthma and chronic obstructive pulmonary diseases, and halon 2402 for fire protection are authorized as specified in annex VI to the report of the Ninth Meeting of the Parties, subject to the conditions established by the Meeting of the Parties in paragraph 2 of its decision VII/28;   To approve the authorization by the Secretariat of the emergency use of 3 tonnes for 1997 for CFC-12 for sterile aerosol talc submitted as an essential-use nomination by United States of America.